文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

斑马鱼幼鱼自然感染模型用于抗分枝杆菌化合物筛选

Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model.
PubMed 文献 · J Antimicrob Chemother · 2016-10-24

研究用发光标记的海分枝杆菌通过浸泡自然感染斑马鱼幼鱼,并验证其用于快速筛选抗分枝杆菌化合物的可行性。用利福平和多种硝基咪唑类药物治疗,发现六种中有五种显著降低幼鱼体内发光信号,且这五种在体外也抑制结核分枝杆菌生长。该模型设备要求低、操作简便,可在普通实验室低成本开展。

要点

  • 斑马鱼幼鱼经浸泡可自然感染发光海分枝杆菌,无需专用设备。
  • 六种治疗中五种显著降低幼鱼体内发光信号,且体外抑制结核分枝杆菌。
  • 该模型适合低成本、低技术门槛的抗分枝杆菌化合物快速筛选。

核心结论

  • 自然感染发光海分枝杆菌的斑马鱼幼鱼可用于抗分枝杆菌化合物的快速筛选,设备易得且技术门槛低。

研究设计与样本

  • 研究用发光标记的海分枝杆菌通过浸泡自然感染斑马鱼幼鱼,并用利福平及多种硝基咪唑类下一代和实验性抗分枝杆菌药物验证模型。

主要发现

  • 六种治疗中五种(利福平、pretomanid、delamanid、SN30488和SN30527)显著降低自然感染幼鱼体内海分枝杆菌的发光信号。
  • 上述五种治疗同样在体外延缓结核分枝杆菌生长。
  • 六种治疗中仅三种(利福平、delamanid和SN30527)在体外延缓海分枝杆菌生长。

临床怎么用

  • 可利用斑马鱼幼鱼自然感染模型,以发光信号为读数,在普通实验室低成本快速初筛抗分枝杆菌化合物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Mycobacterium tuberculosis is a deadly human pathogen that causes the lung disease TB. M. tuberculosis latently infects a third of the world's population, resulting in ∼1.5 million deaths per year. Due to the difficulties and expense of carrying out animal drug trials using M. tuberculosis and rodents, infections of the zebrafish Danio rerio with Mycobacterium marinum have become a useful surrogate. However, the infection methods described to date require specialized equipment and a high level of operator expertise. METHODS: We investigated whether zebrafish larvae could be naturally infected with bioluminescently labelled M. marinum by immersion, and whether infected larvae could be used for rapid screening of anti-mycobacterial compounds using bioluminescence. We used rifampicin and a variety of nitroimidazole-based next-generation and experimental anti-mycobacterial drugs, selected for their wide range of potencies against M. tuberculosis, to validate this model for anti-mycobacterial drug discovery. RESULTS: We observed that five of the six treatments (rifampicin, pretomanid, delamanid, SN30488 and SN30527) significantly reduced the bioluminescent signal from M. marinum within naturally infected zebrafish larvae. Importantly, these same five treatments also retarded the growth of M. tuberculosis in vitro. In contrast, only three of the six treatments tested (rifampicin, delamanid and SN30527) retarded the growth of M. marinum in vitro. CONCLUSIONS: We have demonstrated that zebrafish larvae naturally infected with bioluminescent M. marinum M can be used for the rapid screening of anti-mycobacterial compounds with readily available equipment and limited expertise. The result is an assay that can be carried out by a wide variety of laboratories for minimal cost and without high levels of zebrafish expertise.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Dalton JP, Uy B, Okuda KS, et al. Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model. J Antimicrob Chemother. 2016. PMID: 27798206. doi:10.1093/jac/dkw421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。